SCHEMBL17850573

SCHEMBL17850573

CCN(CC)C(=O)CNC(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
EPHX1 P07099 1/20 0.41
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
PRMT3 O60678 1/20 0.35
MAPT P10636 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TSHR P16473 1/20 0.35
DUSP3 P51452 1/20 0.35
PTPN5 P54829 1/20 0.35
PTPN11 Q06124 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2D6 P10635 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
MMP1 P03956 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17850586 0.88 EPHX1 (0.40) LMNAEPHX1CA12CA1CA2
SCHEMBL17850637 0.85 CA12 (0.46) LMNAEPHX1CA12CA1CA2
SCHEMBL19981641 0.80 ALDH1A1 (0.46) LMNAEPHX1CA12CA1CA2
SCHEMBL13627778 0.77 EPHX1 (0.39) EPHX1PRMT3ALDH1A1HSD17B10TSHR
SCHEMBL24869141 0.77 LMNA (0.46) LMNACA12CA1CA2CA9
SCHEMBL17850653 0.76 EPHX1 (0.49) EPHX1CA12CA1CA2CA9
SCHEMBL19398656 0.74 LMNA (0.52) LMNACA12CA1CA2CA9
SCHEMBL11922838 0.72 LMNA (0.41) LMNACA12CA1CA2CA9
SCHEMBL1241071 0.72 LMNA (0.50) LMNACA12CA1CA2CA9
SCHEMBL9404556 0.71 GAA (0.57) EPHX1MAPTALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2714036-B1 SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS ACHILLION PHARMACEUTICALS INC (US) 2016-06-22 EP disclosed